中国是否出现了对β-内酰胺类抗生素耐药的情况？
Is There Emergence of β-Lactam Antibiotic-Resistant in China?
作者信息
Yu Dingle, Zheng Yuejie, Yang Yonghong
机构信息
Laboratory of Microbiology and Immunology, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing, People's Republic of China.
Department of Respiratory, Shenzhen Children's Hospital, Shenzhen, People's Republic of China.
出版信息
Infect Drug Resist. 2020 Jul 14;13:2323-2327. doi: 10.2147/IDR.S261975. eCollection 2020.
Abstract
is regarded as susceptible to β-lactam antibiotics. The guidelines of the Clinical and Laboratory Standards Institute (CLSI) are widely recognized and have long-recommended penicillin for treatment of infections. There is no CLSI guideline for the treatment of infections that have intermediate susceptibility or resistance to penicillin. However, there have been several reports of isolates that are nonsusceptible or even resistant to β-lactam antibiotics, mostly from Chinese journals. The purpose of this commentary is to show data from the literature which suggests the presence of isolates that are not susceptible to β-lactam antibiotics and whether these strains are really nonsusceptible to β-lactam antibiotics and the presence of mutation in the gene requires further research and confirmation.
摘要
被认为对β-内酰胺类抗生素敏感。临床和实验室标准协会（CLSI）的指南被广泛认可，长期以来推荐使用青霉素治疗感染。对于对青霉素具有中度敏感性或耐药性的感染，尚无CLSI治疗指南。然而，已有几篇报道称存在对β-内酰胺类抗生素不敏感甚至耐药的分离株，大多来自中文期刊。本评论的目的是展示文献中的数据，这些数据表明存在对β-内酰胺类抗生素不敏感的分离株，以及这些菌株是否真的对β-内酰胺类抗生素不敏感，以及该基因中突变的存在需要进一步研究和证实。
相似文献
1
Is There Emergence of β-Lactam Antibiotic-Resistant in China?中国是否出现了对β-内酰胺类抗生素耐药的情况？
Infect Drug Resist. 2020 Jul 14;13:2323-2327. doi: 10.2147/IDR.S261975. eCollection 2020.
2
A Chimeric Penicillin Binding Protein 2X Significantly Decreases in Vitro Beta-Lactam Susceptibility and Increases in Vivo Fitness of Streptococcus pyogenes.A Chimeric Penicillin Binding Protein 2X Significantly Decreases in vitro Beta-Lactam Susceptibility and Increases in vivo Fitness of Streptococcus pyogenes.
Am J Pathol. 2022 Oct;192(10):1397-1406. doi: 10.1016/j.ajpath.2022.06.011. Epub 2022 Jul 15.
3
Reduced Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the Gene Is Geographically Widespread.化脓性链球菌对与该基因中的突变相关的β-内酰胺抗生素敏感性降低在地理上广泛存在。
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01993-19.
4
Isolation of Group A Streptococci with Reduced β-Lactam Susceptibility Harboring Amino Acid Substitutions in Penicillin-Binding Proteins in Japan.日本分离出具有青霉素结合蛋白氨基酸取代的β-内酰胺类药物低敏性 A 组链球菌。
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0148221. doi: 10.1128/AAC.01482-21. Epub 2021 Oct 4.
5
6
Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to β-Lactam Antibiotics.化脓性链球菌 pbp2x 突变导致对β-内酰胺类抗生素的敏感性降低。
Clin Infect Dis. 2020 Jun 24;71(1):201-204. doi: 10.1093/cid/ciz1000.
7
Application of the real-time PCR method for genotypic identification of β-lactam resistance in isolates from invasive pneumococcal diseases.实时 PCR 方法在侵袭性肺炎球菌病分离株β-内酰胺耐药基因分型中的应用。
Microb Drug Resist. 2012 Apr;18(2):149-56. doi: 10.1089/mdr.2011.0102. Epub 2011 Oct 26.
8
Susceptibility of macrolide and beta-lactam antibiotics of Streptococcus pyogenes strains isolated over a four-year period in central Italy.意大利中部地区四年间分离出的化脓性链球菌菌株对大环内酯类和β-内酰胺类抗生素的敏感性
J Chemother. 1996 Jun;8(3):188-92. doi: 10.1179/joc.1996.8.3.188.
9
Low but Increasing Prevalence of Reduced Beta-lactam Susceptibility Among Invasive Group B Streptococcal Isolates, US Population-Based Surveillance, 1998-2018.1998 - 2018年美国基于人群的监测：侵袭性B族链球菌分离株中β-内酰胺敏感性降低的患病率较低但呈上升趋势
Open Forum Infect Dis. 2020 Dec 21;8(2):ofaa634. doi: 10.1093/ofid/ofaa634. eCollection 2021 Feb.
10
Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.巴基斯坦肺炎链球菌、流感嗜血杆菌和化脓性链球菌的抗生素敏感性：2002 - 2015年抗生素耐药性调查（SOAR）结果综述
J Antimicrob Chemother. 2016 May;71 Suppl 1(Suppl 1):i103-9. doi: 10.1093/jac/dkw076.
引用本文的文献
1
Evaluation of the antimicrobial activity of chitosan- and curcumin-capped copper oxide nanostructures against multi-drug-resistant microorganisms.壳聚糖和姜黄素包覆的氧化铜纳米结构对多重耐药微生物的抗菌活性评估
Nanoscale Adv. 2025 Mar 19;7(10):2988-3007. doi: 10.1039/d4na00955j. eCollection 2025 May 13.
2
The Role of Physical Examination and Clinical Scores in Distinguishing Streptococcal Colonization from Pharyngitis in Pediatric Patients: Insights from a Common Clinical Scenario.体格检查和临床评分在区分儿科患者链球菌定植与咽炎中的作用：常见临床场景的见解
Microorganisms. 2025 Feb 27;13(3):529. doi: 10.3390/microorganisms13030529.
3
Emerging β-lactam non-susceptibility in : implications for Ethiopia's healthcare system.新兴的β-内酰胺不敏感性：对埃塞俄比亚医疗系统的影响
JAC Antimicrob Resist. 2025 Feb 21;7(1):dlaf020. doi: 10.1093/jacamr/dlaf020. eCollection 2025 Feb.
4
Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain.侵袭性 A 组链球菌感染（化脓性链球菌）：西班牙的现状。
Rev Esp Quimioter. 2024 Dec;37(6):454-471. doi: 10.37201/req/067.2024. Epub 2024 Jul 30.
5
A Review of the Impact of Streptococcal Infections and Antimicrobial Resistance on Human Health.链球菌感染及抗菌药物耐药性对人类健康影响的综述
Antibiotics (Basel). 2024 Apr 15;13(4):360. doi: 10.3390/antibiotics13040360.
6
The overlooked bacterial pandemic.被忽视的细菌大流行。
Semin Immunopathol. 2024 Jan;45(4-6):481-491. doi: 10.1007/s00281-023-00997-1. Epub 2023 Dec 11.
7
Evaluating antibiotic regimens for streptococcal toxic shock syndrome in children.评估儿童链球菌中毒性休克综合征的抗生素治疗方案。
PLoS One. 2023 Oct 12;18(10):e0292311. doi: 10.1371/journal.pone.0292311. eCollection 2023.
8
[Drug treatment efficacy in 32 children with streptococcal toxic shock syndrome].32例儿童链球菌中毒性休克综合征的药物治疗疗效
Zhongguo Dang Dai Er Ke Za Zhi. 2023;25(9):971-975. doi: 10.7499/j.issn.1008-8830.2306030.
9
A review of penicillin binding protein and group A with reduced-β-lactam susceptibility.青霉素结合蛋白与 A 组β-内酰胺类药物低亲和力的研究综述。
Front Cell Infect Microbiol. 2023 Mar 31;13:1117160. doi: 10.3389/fcimb.2023.1117160. eCollection 2023.
10
Group A Is Still at Large.A组仍然在逃。
J Clin Med. 2023 Apr 6;12(7):2739. doi: 10.3390/jcm12072739.
本文引用的文献
1
Reduced Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the Gene Is Geographically Widespread.化脓性链球菌对与该基因中的突变相关的β-内酰胺抗生素敏感性降低在地理上广泛存在。
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01993-19.
2
Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to β-Lactam Antibiotics.化脓性链球菌 pbp2x 突变导致对β-内酰胺类抗生素的敏感性降低。
Clin Infect Dis. 2020 Jun 24;71(1):201-204. doi: 10.1093/cid/ciz1000.
3
Antibiotic susceptibility of streptococcus pyogenes isolated from respiratory tract infections in dakar, senegal.从塞内加尔达喀尔呼吸道感染中分离出的化脓性链球菌的抗生素敏感性
Microbiol Insights. 2013 Oct 29;6:71-5. doi: 10.4137/MBI.S12996. eCollection 2013.
4
[Clinical characteristics and antimicrobial resistance of invasive group A β-hemolytic streptococcus infection in children].儿童侵袭性A组β溶血性链球菌感染的临床特征及抗菌药物耐药性
Zhonghua Er Ke Za Zhi. 2014 Jan;52(1):46-50.
5
Epidemiological characterization of Streptococcus pyogenes isolated from patients with multiple onsets of pharyngitis.从多次发作咽炎患者中分离的酿脓链球菌的流行病学特征。
FEMS Microbiol Lett. 2011 May;318(2):143-51. doi: 10.1111/j.1574-6968.2011.02252.x. Epub 2011 Mar 11.
6
Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India.印度化脓性链球菌对红霉素的耐药性及青霉素最低抑菌浓度上升。
Jpn J Infect Dis. 2006 Oct;59(5):334-6.
7
Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes.莫西沙星通过E试验对化脓性链球菌的体外比较活性
Clin Infect Dis. 2001 Mar 15;32 Suppl 1:S30-2. doi: 10.1086/319373.
Zotero 插件